Approval · Notice of Compliance 4505 · 1996
LEVOVIST: Notice of Compliance 4505
Issued July 31, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4505
- Date
- July 31, 1996
- Company
- Berlex Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Ultrasound contrast agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEVOVIST | 02227347 | — |
| LEVOVIST | 02229102 | Cancelled Post Market |
Medicinal ingredients
- GALACTOSE 999 MG per G
- PALMITIC ACID 1 MG per G